コンテンツへスキップ
Merck
  • Comparative study of the complex forming ability and enantioselectivity of cyclodextrin polymers by CE and 1H NMR.

Comparative study of the complex forming ability and enantioselectivity of cyclodextrin polymers by CE and 1H NMR.

Carbohydrate polymers (2013-02-13)
Cécile Danel, Nathalie Azaroual, Cédric Chavaria, Pascal Odou, Bernard Martel, Claude Vaccher
要旨

The interactions between nine drugs (baclofen, bupivacaine, chlorpheniramine, ketoconazole, paliperidone, promethazine, propranolol, risperidone and verapamil) and six cyclodextrins (α-CD, β-CD, γ-CD, HP-β-CD, HP-γ-CD and Me-β-CD) or six polymers of cyclodextrins (polyα-CD, polyβ-CD, polyγ-CD, polyHP-β-CD, polyHP-γ-CD and polyMe-β-CD) were studied by affinity capillary electrophoresis and/or (1)H NMR at pH 2.5. An exhaustive qualitative study was performed through the determination of the retardation factor. Then, four compounds and both β-CD and polyβ-CD were selected for the quantitative study of the interactions at pH 2.5 and 7.0. By comparing the results obtained with the β-CD and polyβ-CD, it appears that the apparent binding constants are up to five times higher with the polymer. The 2D-NMR results seem to indicate that the structure of the polymeric network favours the inclusion of the guest in the hydrophobic cavity of the CD units. Moreover, the poly-CDs have shown very high enantioselective abilities at both pH.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
リスペリドン, ≥98% (HPLC), powder
Supelco
リスペリドン 溶液, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®
リスペリドン, European Pharmacopoeia (EP) Reference Standard
システム適合性用リスペリドン, European Pharmacopoeia (EP) Reference Standard